Evidence map›Paper›PMID 42525594›Full record

ReviewTherapeutic advances in respiratory disease

Surgical management of refractory massive hemoptysis from pulmonary artery pseudoaneurysm due to

Khoa Nguyen-Dang, Ngoc Duong-Minh, Nguyen Tran-Ngoc, Loc Nguyen-Dinh, Quoc-Khanh Tran-Le, Thong Pham-Quang, Tien-Bao Nguyen-Van

Abstract readCase ReportsReview
In one paragraph

Review in Therapeutic advances in respiratory disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Khoa Nguyen-DangDepartment of Internal Medicine, School of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.ORCID 0009-0002-3144-7561
Ngoc Duong-MinhDepartment of Internal Medicine, School of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.ORCID 0009-0000-8372-2794
Nguyen Tran-NgocDepartment of Tuberculosis and Lung Diseases, School of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.ORCID 0000-0002-6059-0992
Loc Nguyen-DinhDepartment of Internal Medicine, School of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.ORCID 0009-0002-8195-9231
Quoc-Khanh Tran-LeDepartment of Internal Medicine, School of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.ORCID 0000-0002-7788-3767
Thong Pham-QuangDepartment of Pathology, Cho Ray Hospital, Ho Chi Minh City, Vietnam.ORCID 0000-0002-4706-0225
Tien-Bao Nguyen-VanDepartment of Radiology, Cho Ray Hospital, Ho Chi Minh City, Vietnam.ORCID 0000-0002-6115-560X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary artery pseudoaneurysm (PAP) is a rare but potentially fatal vascular lesion resulting from focal disruption of the pulmonary arterial wall. Although hemoptysis from the pulmonary arterial system is uncommon, PAP carries a high risk of rupture, with reported mortality rates up to 50%. PAP is most often caused by trauma or infection, with pyogenic bacteria and fungi as typical pathogens, while

Indexed as

Aneurysm, FalseHemoptysisPulmonary ArteryStreptococcal InfectionsStreptococcus constellatusThoracic Surgery, Video-AssistedAnti-Bacterial AgentsEmbolization, TherapeuticFemaleHumansMiddle AgedRecurrenceTreatment OutcomeAnti-Bacterial Agentsbronchial artery embolizationcase reporthemoptysispulmonary artery pseudoaneurysmStreptococcus constellatus

Identifiers

PMID42525594
PMCPMC13424749

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.